I am BIO Podcast

Powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.

Episode 76  •  Oct 3, 2023  •  24 min
Biotech Women Striking at the Glass Ceiling

The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women’s success in corporate leadership and mentor the next generation of women executives. 


Episode Guests
Anna Rath
CEO, Vestaron
Grace Colón
Biotech Executive, Entrepreneur and Board Member
Erika Smith
CEO, ReNetX Bio
Recommended Episodes
How Biotechs Survive the Valley of Death
Episode 77  •  Oct 17, 2023  •  25 min

For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry.

Read More
Let’s Get Uncomfortable: Talking About Women’s Health
Episode 66  •  Nov 29, 2022  •  25 min

Talking about women’s health has been a taboo subject for some time, contributing to a lack of innovation in the sector. Still today, many are uncomfortable discussing the topic. Consequently, only 2% of medical products in the pipeline are for women’s health and only 2% of all venture capital dollars go into developing these products. In this episode, we talk with two women in biotech who are trying to change that narrative and infuse more investment in innovations that meet the needs of half the population.

Read More

Contact us

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.